|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.45 USD | -8.19% |
|
-17.58% | -21.53% |
| 07-01 | Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow | CI |
| 07-01 | Harrow Announces Commercial Launch of BYOOVIZ In The United States | CI |
| Market Cap | 1.43B 1.26B 1.17B 1.07B 2.02B 138B 2.05B 13.9B 5.43B 67.86B 5.38B 5.26B 235B | P/E 2026 * |
165x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.43B 1.26B 1.17B 1.07B 2.02B 138B 2.05B 13.9B 5.43B 67.86B 5.38B 5.26B 235B | EV / Sales 2026 * |
4.11x | EV / Sales 2027 * | 2.77x |
| Free-Float |
84.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harrow, Inc.
| 1 day | -8.19% | ||
| 1 week | -17.58% | ||
| Current month | -9.47% | ||
| 1 month | -7.35% | ||
| 3 months | -3.15% | ||
| 6 months | -13.54% | ||
| Current year | -21.53% |
| 1 week | 38.11 |  | 47.14 |
| 1 month | 38.11 | | 47.5 |
| Current year | 28.54 | | 54.85 |
| 1 year | 28.54 | | 54.85 |
| 3 years | 7.6 | | 59.23 |
| 5 years | 5.4 | | 59.23 |
| 10 years | 1.35 | | 59.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 53 | 2011-12-16 |
Andrew Boll
PSD | President | 43 | 2025-08-20 |
Brett Burrell
CMP | Compliance Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Baum
CHM | Chairman | 53 | 2021-08-18 |
Perry Sternberg
BRD | Director/Board Member | 57 | 2022-03-30 |
Adrienne Graves
BRD | Director/Board Member | 71 | 2024-01-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/26 | Free | Director | 5,248 | 0.0141% | ||
| 6/18/26 | Free | Director | 5,248 | 0.0141% | ||
| 6/18/26 | Free | Director | 5,248 | 0.0141% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.19% | -17.58% | +6.24% | +81.11% | 1.43B | |
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | |
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | |
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | |
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | |
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | |
| Average | -0.38% | -0.56% | +24.20% | +55.24% | 364.44B | |
| Weighted average by Cap. | +0.76% | +1.94% | +35.98% | +78.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 348M 306M 285M 261M 491M 33.56B 498M 3.38B 1.32B 16.5B 1.31B 1.28B 57.04B | 517M 454M 423M 388M 729M 49.83B 740M 5.02B 1.96B 24.5B 1.94B 1.9B 84.71B |
| Net income | 9.18M 8.06M 7.5M 6.88M 12.93M 884M 13.13M 89.05M 34.79M 435M 34.47M 33.72M 1.5B | 93.99M 82.55M 76.77M 70.44M 132M 9.05B 134M 912M 356M 4.45B 353M 345M 15.39B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$38.45 | -8.19% | 888,661 |
| 26-07-23 | US$41.88 | -2.22% | 366,233 |
| 26-07-22 | US$42.83 | -2.01% | 382,762 |
| 26-07-21 | US$43.71 | -1.66% | 759,890 |
| 26-07-20 | US$44.45 | -4.72% | 836,731 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HROW Stock
Select your edition
All financial news and data tailored to specific country editions
